Norris Medicines Ltd vs Oxygenta Pharmaceutical Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Norris Medicines Ltd is ₹ 14.11 as of 12 Jun 15:30 . The P/E Ratio of Norris Medicines Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Norris Medicines Ltd changed from ₹ 6.5 crore on March 2021 to ₹ 16.78 crore on March 2025 . This represents a CAGR of 20.89% over 5 yearsThe Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 34.15 crore on March 2022 to ₹ 294.24 crore on March 2025 . This represents a CAGR of 71.33% over 4 years The revenue of Norris Medicines Ltd for the Mar '26 is ₹ 1.43 crore as compare to the Dec '25 revenue of ₹ 3.27 crore. This represent the decline of -56.27% The revenue of Oxygenta Pharmaceutical Ltd for the Mar '26 is ₹ 49.79 crore as compare to the Dec '25 revenue of ₹ 33.93 crore. This represent the growth of 46.74% The ebitda of Norris Medicines Ltd for the Mar '26 is ₹ 0.33 crore as compare to the Dec '25 ebitda of ₹ 0.95 crore. This represent the decline of -65.26% The ebitda of Oxygenta Pharmaceutical Ltd for the Mar '26 is ₹ 0.29 crore as compare to the Dec '25 ebitda of ₹ -4.08 crore. This represent the decline of -107% The net profit of Norris Medicines Ltd changed from ₹ -0.37 crore to ₹ 0.05 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Oxygenta Pharmaceutical Ltd changed from ₹ -1.36 crore to ₹ -1.7 crore over 8 quarters. This represents a CAGR of 11.80% The Dividend Payout of Norris Medicines Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Oxygenta Pharmaceutical Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Norris Medicines Ltd

Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments.
The Company was subsequently converted into Public Limited Company on March 7, 1992.
The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990.
Commercial production of the formulation unit commenced in Nov.'91.
The production unit expanded to manufacture Sterile dosage in form of Ampoules & Vials.

About Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990.
The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited.
Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.
The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.

FAQs for the comparison of Norris Medicines Ltd and Oxygenta Pharmaceutical Ltd

Which company has a larger market capitalization, Norris Medicines Ltd or Oxygenta Pharmaceutical Ltd?

Market cap of Norris Medicines Ltd is 14 Cr while Market cap of Oxygenta Pharmaceutical Ltd is 179 Cr

What are the key factors driving the stock performance of Norris Medicines Ltd and Oxygenta Pharmaceutical Ltd?

The stock performance of Norris Medicines Ltd and Oxygenta Pharmaceutical Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Norris Medicines Ltd and Oxygenta Pharmaceutical Ltd?

As of June 14, 2026, the Norris Medicines Ltd stock price is INR ₹14.11. On the other hand, Oxygenta Pharmaceutical Ltd stock price is INR ₹48.58.

How do dividend payouts of Norris Medicines Ltd and Oxygenta Pharmaceutical Ltd compare?

To compare the dividend payouts of Norris Medicines Ltd and Oxygenta Pharmaceutical Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.